Literature DB >> 2844479

The protean manifestations of familial polyposis coli.

R L Nelson1, C P Orsay, R K Pearl, H Abcarian.   

Abstract

Although familial polyposis coli (FPC) is often thought to be a discrete disease with uniform clinical presentation and few therapeutic options, review of 16 families encountered in the last five years has shown that marked variation in the clinical manifestations of the syndrome is the rule rather than the exception. Thirty one percent of propositi had negative family histories, 67 percent of observed cancers were in the rectum, three individuals from three families developed cancer under the age of 20. In another family the only cancer was in a 67-year-old patient. Polyp growth rate varied tremendously among individuals and over time within individuals, rectal polyps did not regress after subtotal colectomy, and three patients developed rectal cancer after subtotal colectomy (18 percent). Fifty percent of propositi had cancer on presentation, while only 18 percent of screened family members had cancer. The only extracolonic tumors seen were gastroduodenal polyps and retroperitoneal desmoids in three families. The mode of inheritance of FPC causes this variation and treatment is best tailored to the individual and his family rather than uniformly applied to all patients with FPC.

Entities:  

Mesh:

Year:  1988        PMID: 2844479     DOI: 10.1007/bf02552588

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

1.  Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis.

Authors:  D G Evans; S P Guy; N Thakker; J G Armstrong; C Dodd; D R Davies; C Babbs; T Clancy; T Warnes; P Sloan
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

Review 2.  Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature.

Authors:  B Bell; E L Mazzaferri
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.